Skip to main content
Home

Top menu infoNTD

  • About InfoNTD
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoNTD

  • NTDs [14]
    • Buruli ulcer
    • Chagas disease
    • Dracunculiasis
    • Human African trypanosomiasis
    • Leishmaniasis
    • Leprosy
    • Lymphatic filariasis
    • Mycetoma
    • Onchocerciasis
    • Schistosomiasis
    • Snakebite envenoming
    • Soil-transmitted helminthiasis
    • Trachoma
    • Yaws
  • Cross-cutting issues [13]
    • Data management & analysis [3]
      • Data collection and reporting
      • Mapping
      • Indicators
    • Integrated wound management
    • Capacity strengthening
    • Management of disease complications [2]
      • Medical management
      • Surgical management
    • Prevention of disability [3]
      • Eye care
      • Self-care
      • Disability measurement
    • Physical rehabilitation [3]
      • Physical therapy
      • Orthopaedic footwear
      • Protheses, walking devices and wheelchairs
    • Stigma and mental wellbeing [1]
      • Mental wellbeing project mapping
    • Inclusion [2]
      • Community-based rehabilitation
      • Gender
    • WASH and NTDs
    • Health systems factors
    • Skin-NTDs
    • Preventive Chemotherapy
    • Health education
  • Toolkits [5]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • Perception Study Toolkit (PST)
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • NTD Toolbox
    • CBM's Community Mental Health Good Practice Guides
  • Online courses

Top menu infoNTD

  • About InfoNTD
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Evaluating impacts of improved flooring on enteric and parasitic infections in rural households in Kenya: study protocol for a cluster-randomised controlled trial

Halliday KE, Kepha S, Legge H, et al. BMJ. BMJ Open. 2025; 15 (6) : 11.
Download PDF
Publication

Albendazole–ivermectin co-formulation for the treatment of Trichuris trichiura and other soil-transmitted helminths: a randomised phase 2/3 trial

Krolewiecki A, Kepha S, Fleitas PE, et al. Elsevier BV. The Lancet Infectious Diseases. 2025; 25 (5) : 548-559.
Download PDF
Publication

Assessment of a decentralization model in improving treatment and care of visceral leishmaniasis in Turkana County, Kenya: A mixed method study

Mbui J, Macharia M, Maranga D, et al. Public Library of Science (PLoS). PLOS One. 2025; 20 (5) : 1-15.
Download PDF
Publication

Building the future One Health workforce in Eastern and Southern Africa: Gaps and opportunities

Wako BY, Richards S, Grace D, et al. CABI Publishing. CABI One Health. 2025; 4 (1) : 11.
Download PDF
Publication

Barriers and facilitators of care among visceral leishmaniasis patients following the implementation of a decentralized model in Turkana County, Kenya

Macharia M, Okoyo C, Maranga D, et al. Public Library of Science (PLoS). PLOS Global Public Health. 2025;
Download PDF
Publication

Safety and effectiveness of triple-drug therapy with ivermectin, diethylcarbamazine, and albendazole in reducing lymphatic filariasis prevalence and clearing circulating filarial antigens in Mombasa, Kenya

Khaemba C, Njenga SM, Omondi WP, et al. Springer Science and Business Media LLC. Infectious Diseases of Poverty. 2025;
Download PDF
Publication

Systems thinking in the prevention, control, and elimination of neglected tropical diseases (NTDs)

Makau-Barasa LK, Kamara K, Karutu C, et al. Elsevier BV. International Journal of Infectious Diseases. 2025;
Download PDF
Publication

Efficacy of single dose praziquantel against Schistosoma mansoni in East Africa: a systematic review and meta-analysis

Sisay M, Hailu T, Damtie D, et al. Springer Science and Business Media LLC. Scientific Reports. 2025;
Download PDF
Publication

Lymphatic Filariasis Elimination in Kenya: Tracing the Journey from 2002 - 2024 and Pathways to Achieving 2030 Target

Ofire MO, Omanje V, Sempele I, et al. Elsevier BV. International Journal of Infectious Diseases. 2025;
Download PDF
Publication

Weekly Epidemiological Record: Elimination of visceral leishmaniasis as a public health problem in Kenya – progress and challenges

World Health Organization . World Health Organization. 2025;
Download PDF

Pagination

  • Page 1
  • Next page ››
Subscribe to Kenya

Quick Links

  • Toolbox
  • Publications
  • Organizations
  • NTDs

Support

  • Contact
  • FAQ
  • Privacy statement

Contact us infoNTD

info@InfoNTD.org

(+31) 20 595 0526

     

Stay up to date with the latest developments in NTDs. We share a monthly overview via email showing a selection of the latest NTD publications and tools. 

Subscribe

Related websites NTD:

  • Infolep

© 2025 InfoNTD